IPR and Tribal Sovereign Immunity
Following the Oil States decision in which the Supreme
Court invoked the public rights doctrine to protect the Patent
Trial and Appeal Board's (PTAB) authority to invalidate patents
by inter partes review (IPR), the Federal Circuit used a
similar line of reasoning to determine whether tribal sovereign
immunity could bar this form of patent review.
Saint Regis Mohawk Tribe v Mylan Pharms. Inc originated
as a patent infringement dispute between private pharmaceutical
companies Allergan and Mylan. Mylan challenged the Allergan patents
in an IPR. A week before the PTAB was to hear arguments in the IPR
proceeding, Allergan assigned the patents to the Saint Regis Mohawk
Tribe, which then sought to terminate the IPR by asserting tribal
sovereign immunity.